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PART 1: INTRODUCTION
Traditional Knowledge - Definition
Tradition in the expression 'traditional knowledge'(TK) does not mean old but refers to
the manner of producing knowledge. Hence TK refers to knowledge that has been
developed based on the traditions of a certain community or nations. 1 TK is one of the
many existing systems of knowledge. The TK system constitutes a rich 'and diverse
intellectual heritage. It is embedded in a wide array of cultures and sustains a broad
spectrum of ways of life. 2 The knowledge and its contribution is dynamic and continuous.
Value olTK
1. Indigenous knowledge systems have helped to preserve and enhance biodiversity.
Indigenous peoples nurture nature and its bounty especially as it provides them
with the wherewithal for their very survival. Indigenous peoples and local
communities have been developing seeds and food crops, using plants, animals,
microbes and microorganisms to heal and clothe themselves. It is their innovation
over millennia that has fed, clothed and healed the world. And these continue to
do so.
International acknowledgment
The best international acknowledgement of this is the Convention on Biological
Diversity (CBD). The CBD asks countries to
• Paper presented at the Conference on: 'The Interface between Traditional Knowledge and Intellectual
Property', organized by the Bar Council, Malaya and AIPPI, Malaysian Chapter, I September 2006, Kuala
Lumpur, Malaysia.
IWeerawit Weeraworawit, 'International Legal Protection of Genetic Resources, TK and Folklore:
challenges for the IP system', in Trading in Knowledge, Bellman, Dutfiled and Melendez-Ortiz (eds),
Earthscan, 2003, p. 157 at p. 159.
2 Nakashima D, 'TK: Resisting and adapting to globalisation' in as above, p. 131.
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• Respect, preserve and maintain knowledge, innovations and practices of
indigenous and local communities embodying life styles relevant for the
conservation and sustainable use of biological diversity;
• Promote their wider application; and
• Encourage the sharing of benefits arising from its utilization.
Article 8(j)
• Protect and encourage customary use of biological resources in
accordance with traditional cultural practices that are compatible with
conservation and sustainable use of biological resources.
Article 10 (c)
• Facilitate the exchange of information relating to indigenous and
traditional knowledge.
Article 17(2)
• Encourage and develop methods of cooperation for the development and
use of indigenous and traditional technologies.
Article 18(4)
2. TK value can also be seen from its immense economic contributi~n to modem
industries -pharmaceuticals, botanical medicines, cosmetics and toiletries,
agriculture and biological pesticides, amongst others.
The monetary estimation is made more difficult as often TK is often an essential
component in the development of other products; and most TK-derived products
never enter the market.
Agricultural crops
According to a study commissioned by the UN Development Programme, genes
from the fields of developing countries for only 15 major crops contribute more
than US$50,000 million in annual sales in the US alone.' Often the main
beneficiaries are the countries and corporations of the North. The Rural
P:dvancement Foundation International (RAFI), an international NGO, has
estimated the value of farmer's varieties to both the food consumption and the
agricultural earnings of developed countries. The International Maize and Wheat
Centre (located in Mexico) contributes US$2,700 million in crop production in
industrialised countries. For rice, from the International Rice research Institute,
the contribution to the rice production of developed countries is estimated to be
US$655 million per year. For beans the estimate is about US 111 million from
3 Conserving Indigenous Knowledge, An Independent Study by the Rural Advancement Foundation
International, Commissioned by the UNDP, p.27.
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material provided by the International Centre for Tropical Agriculture." Industrial
country agriculture also benefits enormously from the germplasm from potato,
chickpea, barley, livestock breeds and many other materials from largely
indigenous communities in developing countries. The global value added to rice
yields by use of land races - traditional crop varieties - is estimated at US$400
million per year. (Dutfield - Unctad p. 144).
Pharmaceuticals
The same contribution obtains for pharmaceutical biodiversity. Three-quarters of
plants that provide active ingredients for prescription drugs came to the attention
of researchers because of their use in traditional medicine.i Among the 120 active
compounds currently isolated from the higher plants and widely used in modem
medicine today, 75% show a positive correlation between their modem
therapeutic use and the traditional use of the plant from which they were derived.
More than two thirds of the world's plant species - at least 35,000 of which are
extimated to have medicinal value --{;ome from developing countries. At least
7,000 medical compounds in the western pharmacopeia are derived from plants.
According to one estimate, the annual value of developing country germplasm to
the pharmaceutical industry was as high as US$47,000 million as at 2000.6 RAFI
estimates that US$32 billion of sales of pharmaceuticals world-wide are based on
traditional medicines. Yet the developing countries' exports were only US$551
million - an incredible shortfall. The importance of medicinal plants is
highlighted by the work of the US National Cancer Institute. Between 1986 and
1992, it paid for the collection of 23,000 plant samples of 7,000 species, almost
all of which came from the countries of the South.
Soil bacteria
The contribution of indigenous peoples to world health comes also from
medicines derived from the soils. Several leading pharmaceutical multinationals -
Merck, Pfizer, Bristol Myers - are busy collecting micro-organisms from the soil
from the developing world. Indigenous peoples have long known and valued the
properties of certain soils. They may not be aware of the exact bacteria or fungi
resident in the soil, but they know of the anti-tumor, antibiotic or steroid
characteristics of certain soils.
At least 12 % and 4% of the bacterial accessions in the American Type Culture
Collection are derived form developing countries, mostly from soil samples. In
1990, for example, the University of Florida patented a Brazilian fungus known
4 ibid. pp. 27-28.
5 Kloppenburg, J. Jr., 'No Hunting! Biodiversity, Indigenous Rights, and Scientific Poaching', Cultural Survival
Quarterly, summer 1991, p. J 5
6 see UNDP report, fn 2, at p. 30.
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to be lethal to fire ants that can cause more than a billion dollars in damage to US
crops. Brazilian farmers were aware that something in the soil kills fire ants.
3. Its value in enhancing and integrating indigenous and local communities by its
cultural and spiritual values. This is of course, not measurable in economic terms.
PART 2: THE START OF THE MARGINALIZATION OF TK - THE
EMERGENCE OF OWNERSHIP RIGHTS IN RESOURCES AND ASSOCIATED TK
An open system: common heritage of mankind
Traditionally, genetic resources have been considered as the common heritage of
mankind. They were freely accessible to all. This was publicly proclaimed - in relation to
plant genetic resources - by the International Undertaking on Plant Genetic Resources - a
non-binding agreement concluded under the auspices of the UN Food and Agriculture
Organisation (FAO). Plant genetic resources were in the global commons and no country
had the exclusive right to prevent others from accessing and using them. There was also
no concept of sovereign rights in genetic resources.
Then it all started ...
What contributed to the emergence of property rights for commercial benefits in this area
was the enactment in the early 1960s of an international convention - the Union for the
Protection of New Plant varieties (UPOV - following the acronym from its French
name). The South, where the biodiversity was concentrated, was tapped freely for source
material - farmers' germplasm. Corporate interests - almost entirely from the North -
invaded the local commons of the South for free, made 'improvements' in the breeding
process by modifying the plant variety's characteristics and quality, and claimed property
rights. The innovative contribution and knowledge of local communities to the evolution
of seeds and genetic resources were ignored and remained unrewarded. This inequitable
exploitation on the basis that the resources were 'the common heritage of mankind' could
not continue unabated. It spawned a debate in the FAO in the 1970s. The Undertaking
was adopted in 1983. The debates finally led to the recognition of both Plant Breeders'
and Farmers' Rights in 1989.7 An international gene fund was set up to finance the
conservation and utilization efforts of farmers. But this fund remained inoperative as
there were no contributions by the corporations and the countries of the North.
On 3 November 2001 under the auspices of the FAO a binding agreement was adopted -
the International Treaty on Plant Genetic Resources for Food and Agriculture. It
incorporates farmers' rights and a mutilateral system for access and benefit sharing - of
which more will be discussed later.
7 See further: Gurdial Singh Nijar, In Defence of Local Community Knowledge and Biodiversity. TWN,
Paper I, 1996, pp.6-9.
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Patent rights and biotechnology
The inequity was further extended by the extension of patent rights to living organisms
and later to genetic material - by article 27.3 (b) of WTO/TRIPS. Even of greater impact
were patents in relation to discoveries especially in the biotechnology field. The
'products of nature' doctrine was circumvented by allowing for the patenting of isolated,
purified, and identified gene sequences. The holder of a patent on such gene could
prevent others downstream from making or using that gene. The IPRs recognized
included, as well, products based on or derived from TK.
PART 3: THE CONCEPTUAL 'BASIS' FOR THE IMPAIRMENT
1. Differing world view of reality
There is a fundamental differing world view of reality between the traditional and the
scientific. Scientists adjudge only that which is verifiable by their criteria as reflecting
reality. The rest - like TK - is considered unscientific, not rational and therefore
incapable of reflecting and understanding reality. In other words, science is deemed a
superior knowledge system to TK. Given the institutional power of science in mainstream
society, it adjudges other knowledge systems.
2. The usurpation ofTK through IPRs?
This conceptual bias was then universalized through internationally binding trade
agreements - mainly as established by the WTO/TRIPS agreement. The definitional
constructs for obtaining patents and other intellectual rights recognises and rewards the
creativity of individuals not communities; one-off 'inventions' as against inter-
generational community innovations; and inventions made for the market place as
distinct from those for the social good. In other words the scheme appears inherently
incompatible with according protection and recognition of the innovations at the heart of
TK knowledge systems. This has resulted in the usurpation of TK and the failure to
provide fair and equitable compensation to the creators and holders of this knowledge.
3. The marginalization ofrK
The result is that resources are acquired by industry - directly or indirectly from the TK
knowledge systems - and monopolistic ownership claims are made over these. This leads
in the long term to the marginalisation of the knowledge system itself. For only the
creativity of the industry is rewarded in the general scheme of patent law. Even if
communities could afford to do so, it is clear that industry is in an advantageous position
compared to communities to claim a patent. Communities may know of the useful trait
and use of a plant or animal. But patents are given to those who can describe the
phenomenon in the language of chemistry or molecular biology and patent law. A
5
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company may not get that patent by simply describing the mode of action or the active
compound - but it could claim a patent for the synthetic version of the compound or
even a purified extract. (Dutfield - p. 145).
4. Thefragmentation and atomization of the cultural system.
Additionally industry acquires select elements of the resource in isolation from the larger
cultural context of indigenous and local communities. This encourages fragmentation and
atomization of the cultural system. For example, dissension and social discord is
triggered when those from amongst the community are designated 'owners' of a
community knowledge resource.
5. The intervention of the market place.
Also, local knowledge is delivered - through conventional IPRs - to the global market
place in which communities are ill-suited to participate.
PART 4: THE RESULT: INEQUITY, BIOPIRACY, MARGINALSIATION OF
TK
Western companies often synthesize derivatives .of plant mixtures used and identified by
indigenous peoples by modifying the molecular structure of one of its active ingredients.f
Everyone involved in the process benefits enormously. Except, of course, those
indigenous peoples who developed the product in the first place! Such 'usurpation of the
knowledge of indigenous peoples - referred to as 'biopiracy' - continues unabated post-
CBD. The examples of biopiracy are too numerous to recount. From the neem plant of
India to the devil's claw of Southern Africa, to the sacred sangraderago of South
America. Pharmaceutical companies are the main beneficiaries of this biopiracy.
Some examples: the root of the serpent-wood species rauvolfia serpentina, widely used
for centuries in India for a number of maladies including hypertension, is a classic
example of the commercialisation of indigenous knowledge. By 1967, almost 90% of the
anti-hypertensive drug market in the US was based on these roots, and the tree continues
to be the basis of several other important medicines.I Companies from the US and Japan
have been granted some 34 patents for various uses and processes relating to the nee~
tree. Yet Indian traditional knowledge of the use of the neem dates back 5,000 years. It is
part of their Ayurved knowledge system. The US National Research Council recently
noted that the people of India treasure the neem tree as a local pharmacopeia:
'For centuries, millions have cleaned their teeth with neem twigs, smeared skin
disorders with neem-leaf juice, taken neem tea as tonic, and placed neem leaves in
their beds, books, grain bins, cupboards, and closets to keep away troublesome bugs.
8 See the example of the curare, later in the text.
9 Axt, supra, p.7.
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The tree has relieved so many different pains, fevers, infections, and other complaints
that it has been called the 'village pharmacy'. To those millions in India neem has
miraculous powers, and now scientists around the world are beginning to think they
may be right.' 10
While acknowledging and drawing upon the knowledge systems of indigenous peoples
and profiting hugely as a result, the knowledge itself is deprecated as being primitive.
PART 5: RESTORING THE BALANCE
1. Integration ofTK into scientificframeworks?
Could the integration of two knowledge systems - the traditional and the SCIentifIc be the
solution to maintaining the viability of TK? After all, science recognizes TK as a
valuable resource in their research and especially in cutting lead time for the final
development and creation of a product. However integration has led, or could lead, to the 0
extraction of relevant knowledge through a process of scientific validation - ostensibly to ~
separate the 'useful' from the 'useless', the objective from the subjective, knowledge ~
from belief. This may be good for science - but it could result again to the 0 ~.r!
dismemberment and fragmentation o.f TK sys.tem.s and the accelerat~on of the demise of ~ ~
the TK system and its replacement WIth the SCIentific system. (Nakshima 132/3). ~ ~
;::J~
z~-< ,.,~ .....
~?:<~t.. :.:>
2. Acknowledging the co-existence of the two knowledge systems
There needs to be recognition that TK and the scientific knowledge system are plural and
differing systems that conceive the world in completely different ways. The TK world is
a place with pathways between the natural and societal realms - where spirituality infuses
everyday objects and everyday acts. (Naka 133) More importantly, there is no objective
basis for suggesting that one view is superior to the other. The 'pre-eminence' is as a
result of a societal choice - by a self assertion of the predominant - and is not defensible
from any neutral or acultural perspective.
How, for example, can scientists possibly suggest that indigenous peoples stumbled by
pure chance as to the properties of the curare plant. Several millenia ago, the Amazonian
.hunters developed this muscle-paralvzing substance as a.blow-gun poison. It kills tree-
borne animals without poisoning the meat while causing them to relax their grip and fall
to the ground. Monkeys hit with an untreated arrow wrap their tails around branches and
die out of the hunter's reach. Modem medicine realized the vast potential of the curare in
surgery. For it. interrupts nerve impulses and relaxes all muscle including breathing
muscles. There are forty types of curares in the Amazon made from seventy plant
species. The kind used in modern medicine comes from the Western Amazon. It is
produced by combining several plants and boiling them for seventy-two hours. The
10 see further, Nijar, TRlPS and Biodiversity: The Threat and Responses, 1996, Third World Network,
Paper 2, pp. 14-15.
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mortal fragrant vapors emitted by the boiling have to be avoided. The final product is a
paste that is inactive unless injected under the skin. If swallowed, it has no effect. As
Narby notes:
'When one asks these people about the invention of curare, they almost invariably
answer that it has mythical origin. The Tukano of the Colombian Amazon say the
creator of the universe invented curare and gave it to them. ,II
Western 'science' may attribute the manner of the acquisition of the knowledge to pure
chance and accidental 'stumbling upon' a result; or at its most charitable, the result of
cumulative years of this happening. But traditional cultures have quite different
explanations. The Quirishari living in the Amazon, for example, say they know that a
plant cures the potentially mortal bite of the jergon snake from the pair of white hooks
resembling snake fangs embossed on the plant. 'We know this thanks to these hooks,
because that is the sign nature gives. ,12 Indeed ethnobotanists no longer dismiss the
possibility that there is a communion between nature and indi~enous peoples that yields
this vast information. The foremost ethnobotanist of the 201 century, Richard Evans
Schultes, writes about the healers of a region in Colombia that he considers as one of the
centres of Western Amazonian shamanism
'The medicine men of the Kamsa and Inga tribes of the Valley ofSibundoy have
an unusually extensive knowledge of medicinal and toxic plants .., One of the
most renowned is Salvador Chindoy, who insists that his knowledge of the
medicinal value of plants has been taught to him by the plants themselves through
the hallucinations he has experienced in his long lifetime as a medicine man. ,/3
Our bias, or worst, ignorance, should not be the basis of a hierarchy of recognition; both
knowledge systems should be equally regarded. TK is not just random bits of information
but integral components of dynamic societies and cultures.
PART 6: LOOKING AT AREAS TO ASSIST RESTORATION OF THE
BALANCE: OPTIONS FOR DEVELOPING COUNTRIES AT THE
INTERNATIONAL AND THE NATIONAL LEVELS
There has been a momentum by developing countries in various international fora for
proactive measures to prevent the misappropriation of genetic resources and associated
TK - spurred on by the CBD provisions relating to TK. There have been numerous
proposals. These range from the creation of new forms of stand alone forms of protection
of community._intellectual knowledge to the simple option of simply preventing any
11 See footnote 3, at pp. 39-40.
12 Quoted in Jeremey Narby, The Cosmic Serpent, DNA and the Origins 0/ Knowledge', Phoenix 1999, p.
29.
13 Schultes and Raffauf, The Healing Forest: Medicinal and Toxic Plants of the Northwest Amazonia,
Dioscorides Press, 1990, quoted in Narby, ibid, at p. 41.
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forms of IPRs over such knowledge. Some of the efforts of developing countries are
explored - both at the international and national level.
A. THE INTERNATIONAL FRAMEWORK
I. IN THE CONTEXT OF WTO/TRIPS
Theproposals of developing countries at the WTO TRIPS Council
Under the CBD, the country of origin regulates access rights and is entitled to the
benefits. 'Country of origin' is defined as the country which possesses those genetic
resources in in-situ conditions, that is, within ecosystems and habitats. In the case of
domesticated and cultivated species, where the genetic resources have developed their
distinctive properties." 'Habitat' is defined as the place or type of site where an
. I . II 15organism or popu anon natura y occurs.
Developing countries at the WTO are seeking to require disclosure of the country of
origin of the material and associated TK in patent applications as a mechanism to prevent
its unauthorized use and ensure the sharing of benefits. 16 They wish to make the WTO
provisions compatible with the CBD provisions relating to access and benefit sharing of
genetic resources and associated TK. They argue that this could effectively prevent their
misappropriation.
Theproposals of developing countries at the WTO TRIPS Council
After a long gestation period and much rancorous debate, nine developing countries'{ the
proposal was formally submitted" on 31 May 2006.
The proposal seeks to amend the TRIPS Agreement - in particular Articles 27.3 and 2919
- to require, as a condition for patent grant:
14 Article 2 - defining 'country of origin' and 'in-situ conditions' \
15 A . 1rue e 2 CBD.
16 These definitions give rise to a whole host of problems. This is made more so when genetic sequences
usually appear in more than one country. Where can a gene be said to have developed its distinctive
properties? Where did the gene naturally occur? Tension is likely to develop over these uncertainties -
especially amongst developing countries seeking to capture the benefits of allowing access and use of its
genetic material. Rubber and palm oil in Malaysia, for example, were brought from Brazil and Africa
respectively during colonial rule. Over the years these resources have been developed, and can be said to
have acquired, distinctive properties. But is the distinctiveness unique enough and, more importantly, is this
fact accepted by those countries from where the resource was first taken?
17 Brazil, India, China Pakistan, Peru, Thailand and Tanzania. A revised version adds China and Cuba as
cosponsors.
18 WT/GC/W/564.
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a. the disclosure of the source and country of origin of the genetic resources
including TK used in the invention;
b. evidence that the country of origin had consented to its extraction and use;
c. evidence of fair and equitable sharing of benefits under the national regime.
The international framework of protection envisaged would have as key features a
mandatory certification from the country of origin when applying for a patent - a
certificate of origin - ensuring these three aspects.
The rationale offered: need for international framework to supplement national regimes
This, say the developing countries, is imperative to implement TRIPS and the CBO in a
mutually supportive way. In particular, these proposals would be a vital supplementary
measure to national regimes and a necessary incentive for patent applicants to comply
with the prevalent laws and practices of the countries of origin of the genetic resources
including TK, in accordance with the objectives and norms of the CBO. More
importantly, they argue that the proposals highlight the fact that bio-piracy is a global
problem mostly involving the acquisition of material and TK in one country and the
seeking of a patent over that material or inventions deriving from that material and TK, in
another country. National regimes would not be sufficient to protect and fully preserve
biological materials and associated TK, given the transnational facet of the problem. The
problem was that any effort by national patent offices and other national authorities to
prevent bio-piracy, as well as to enforce prior informed consent and benefit sharing
mechanisms, does not automatically lead to similar actions in respect of patent
applications in other countries.
A paper commissioned by the Secretariat of the CBO states that the CBO places the
responsibility of ABS on both the user and the source provider. Yet each country's
n~ ional legislation - both in developed and developing countries - emphasise almost
exclusively on access to the genetic resources of that country. The paper notes that little
relevant user laws have been adopted:
'At present, developed country legislation does not appear to address the separate
requirement of the adoption of legislation or other measures with the aim of
sharing in a fair and equitable way ... the benefits arising from the commercial
and other utilization of genetic resources as required in Article 15.7'. It is
certainly perceived not to support any attempt to enforce ABS requirements of
source countries. Claimants seeking remedies or enforcement of ABS principles in
these countries, would be forced to use basic provisions of contract and property
19 The TRIPS Agreement is understood as pennitting members to introduce obligation to disclose the origin
of genetic resources and TK in patent applications. This proposal obliges members to introduce mandatory
obligation. Hence the need for an amendment.
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law, which evolved centuries before any concept of genetic resources as property,
and which do not provide any legal basis for ABS actions '.20
A brief background to the emergence of these proposals
In the Uruguay Round negotiations that led finally to the WTO, the relationship of trade
and biodiversity - the WTO and the CBD, and in particular the protection of the
innovations of indigenous and local communities - was not discussed at all.21 Discussions
on the relationship began in 1995 in the WTO in the Committee on Trade and
Environment. Developing countries introduced these discussions in the TRIPS Council -
that is the institutional body in charge of TRIPS - when Article 27.3(b) came up for
review in 1999. By the time of the Seattle WTO Ministerial meeting, developing
countries had proposals to amend TRIPS to include TK. There was no outcome on this
issue but clearly the momentum was gaining pace and discussions continued through
2000 - 2001 about the relationship between the CBD and TRIPS. The breakthrough came
at the Doha Ministerial. The Ministerial Declaration at this meeting instructed the TRIPS
Council to examine, among other things, the relationship between TRIPS and the CBD
and the protection of TK and folklore. Paragraph 12 identified it as an outstanding
implementation issue. This was then discussed at the TRIPS Council and is now part of
the outstanding issues at the Trade Negotiations Committee (TNe) level. The declaration
of the December 2005 Hong Kong Ministerial requested the WTO director general to
"intensify his consultative process" and report to the Trade Negotiations Committee and
the General Council, which will consider progress and "take any appropriate action" by
the end of JUly.
Three broad approaches
At these discussions, 3 broad positions have emerged. The first, says there is an inherent
conflict. Hence the need to reconcile the 2 treaties as part of the review process of Article
27 .3(b). The second, is that there is no legal conflict at all. The third is that both these
treaties should be read in a mutually supportive way. On this view, there is no need to do
anything at the national or international level. However a group of developing countries
feel that to avoid the potential for conflict, there is need to amend TRIPS. The proposals
for amendment by the 9 countries are in support of this position.
Elaboration of the proposals:
Fair and equitable sharing enhance credibility of patent system
20 UNEP/CBD/WG-ABS/4/INF/6, IUCN-Canada, Analysis of Claims 0/ 'Unauthorised Access and
Misappropriation of Genetic Resources and Associated TK' IUCN-Canada, 2005, at p. 28.
21 'The question of newforms of protection adapted to theparticular circumstance of indigenous
peoples/communities was not raised during the TRlPS negotiations', comments by The Committee on
Trade and Environment, : WTICTE/W/8.
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The proposers suggest that providing evidence of fair and equitable benefit sharing
arrangements arising out of the utilisation of the genetic resources
22
and TK in the
invention with the source and country of origin and/or local/indigenous community is fair
and would enhance the patent system's credibility.
The following factors are suggested to determine whether there is equitable and fair
benefit sharing. First, the sharing of benefits is premised upon mutually agreed terms -
MAT _ in the context of Article 15(7) of the CBD, covering elements relating to the
conditions, obligations, procedures, types, timing, distribution and mechanisms of the
benefits shared. Secondly, there is a reporting obligation on issues relating to patenting or
commercialisation especially where future benefit sharing is contemplated.
Where no national regime on ABS
Where there is no national regime, the patent applicant must declare that there was no
national access and benefit sharing regime in the country of origin, but that there was,
in any case, benefit sharing or an arrangement for future benefit sharing with the
authority or community in charge of the location where the genetic resources and TK
were accessed, in a manner that fully respects the prevalent laws, regulations and
practices of the country of origin.
Effect where no benefit sharing
Where genetic resources and TK were used in an invention but no evidence of benefit-
sharing or an arrangement for future benefit sharing has been furnished as required
before the examination or grant of a patent, the legal effect could be that the application
would not be processed any further until the submission of the necessary declaration
and evidence.
Sanctions and penalties
This could be accompanied with penalties, including criminal penalties, and time-limits
within which the proper declaration and evidence must be provided. Otherwise the
application could be deemed withdrawn. The failure to provide evidence of benefit
sharing should justify the non-processing of the application.
Where the failure to provide evidence of benefit sharing is discovered after the grant of a
patent, the legal effect could include:
• Revocation of the patent where it is determined that there is fraudulent intention
behind the failure to provide evidence of benefit sharing. Additionally or
alternatively, criminal and/or administrative sanctions may also be imposed,
particularly to ensure adequate compensation where it is eventually determined
that no benefits were shared or are intended to be shared;
22 This term would include derivatives. See later text at p.
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• Full or partial transfer of the rights to the invention, also as an alternative to
revocation.
• Criminal and/or civil sanctions, outside the patent system, including the
possibility of punitive damages, where it is determined that the patent holder in
fact provided benefits but did not provide the evidence in the application.
Responses from the developed countries
So far the response to the proposals from the developed countries has been mixed. The
US, in particular, sees no conflict between the CBD and TRIPS, and argues that CBD
obligations can be satisfied by taking action at the national level, without the need for
action to be taken on the patent system or at the WTO. Essentially, the US argues that
these requirements are extraneous to the criteria for establishing the grant or refusal for a
patent - namely, that the patent is new, involves an inventive step and has industrial
utility. The European Union's position is that it could agree with the proposals of the
developing countries as a basis for discussion; however it does not agree with the
proposals requiring disclosure of evidence of prior informed consent and benefit sharing.
It is also against any form of penalties under patent law.
A large number of countries support the continued discussion on disclosure, and are
agreeable to the suggestion that the future meeting discuss the form and content of the
proposals."
The text-based amendment presented by developing countries on 6th June 2006
On 6th June 2006 the developing countries presented actual text. They suggest that
countries are now ready to begin text-based negotiations, without committing them
beforehand to agree to the amendment of TRIPS in the end.
The text-proposal is to create a five-paragraph Article 29bis in the TRIPS agreement
establishing requirements for the disclosure of origin of biological resources and
traditional knowledge. Article 29 relates to conditions on patent applications, including
disclosure of the invention details. The proposal would require greater detail in the
, disclosure of the country providing the resources as well as the country of origin "after
reasonable inquiry." It also would require evidence of compliance with legal
requirements in the providing country for prior informed consent to access the resources,
and fair and equitable benefit-sharing of commercial uses. Other measures include
required updates and enforcement.
23 The Report of the last TRIPS Council of the WTO agreed that the 'work (on the relationship between the
TRIPS and the CBD) continue on the basis of para 19 of the 200 I DOHA Ministerial Declaration and the
progress made in the Council for TRIPS todate': S. Shashikant, TRIPS transition period for LDCs extended
by 7.5 years with conditions, Third World Economics, TWN, issue 368,1-15 Jan 2006, 21 at 22.
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The developed country opponents - mainly Australia, Canada, Europe and the United
States - say there is nothing new in the presentation and continue to hold the view that it
is premature to consider an amendment to TRIPS to address concerns about
misappropriation of genetic resources and traditional knowledge; or they argue that the
proposed amendment is too broad.
Many more developing countries are considering supporting the proposals." Colombia,
Ecuador, and Venezuela are discussing the amendment matter in their capitals, with at
least Colombia indicating it may sign on. Argentina, cited as an opponent, has softened
its position to say it is under discussion in the capital as well. There are also other
countries considering signing on.
However, the Philippines, Singapore and Taiwan have raised concerns. Singapore is
reported to have said that an approach to preventing misappropriation through contracts
has been effective, but did not provide examples. The Philippines raised technical
questions but indicated support for the objective.
Norway, which has stated support for discussing the matter at the WTO, said it would
produce its own proposal, possibly watering down provisions on prior informed consent
and benefit sharing, according to a source. The European Union, speaking for 25
countries, cited its proposal at the World Intellectual Property Organization and said it
will be a "challenge" to reconcile the two. However, the EU and Switzerland appear not
be opposed to discussing the matter at the WTO, and Brazil explicitly stated that the
WTO is the proper venue, the source said. .
Switzerland prefers disclosure through WIPO's Patent Cooperation Treaty."
The outcome of negotiations, should they occur - according to IP Watch quoting as
devel ping country source - could be somewhere between the proposed WTO
amendment and the EU's WIPO proposal. The EU proposal differs from the WTO
proposal in at least two key ways. First, it would limit the focus to disclosure of origin of
genetic material directly used in the invention. The proposed WTO amendment would
require disclosure of origin whether directly or indirectly used in the invention, and
would extend to traditional knowledge as well.
In addition, the European Union views some terms in the WTO amendment proposal as
too l broad. The EU proposal would use the term 'genetic resources'. It views the
developing countries term 'biological resources' as too broad. And the European Union is
concerned about the burden put on patent applicants by use of the term 'reasonable' in
determining their requirements for proper disclosure.
24 Report by IP Watch: http:// ip-walch.org/weblog/wp-trackbackphp?p=326.
25 At the 6 June meeting, Switzerland said its priority is for the extension of elevated GI status to other
products beyond wines and spirits.
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Japan, Korea and the United States continue jo argue that there is no actual mandate to
negotiate on this issue. In the 6 June meeting, the United States was challenged to put
forward the precise legal reason for this, but apparently failed to do so.
The CBD issues are indirectly tied to the GIs talks, as the proponents of each have shown
willingness to possibly support the others' proposal in exchange for support of their own,
sources said. Under this theory, Australia's opposition to CBDs could be explained by its
staunch opposition to GIs, one source said.
Informal special session on 14 June 2006
At a special session of the TRIPS Council on 14 June, Japan and Norway tabled their
proposals. The position now is that while there are a number of proposals, there is no
common text that could be the basis for future negotiations.f"
Norwegian proposal
The Norwegian proposal - no different from its earlier one - supports the idea of
amending the TRIPS agreement to make disclosure of origin and the source of genetic
resources and traditional knowledge mandatory in patent applications, but differs when it
comes to sanctions. Patents would not be revoked if incorrect or incomplete information
has been given in the patent applications, which is identified after the patent is granted.
The Norwegian proposal says this should be penalised outside the patent system.
It calls for mandatory disclosure only of the country of origin, not of prior informed
consent and benefit sharing. Only if the national law requires prior informed consent
from the provider, should this requirement be met as well. Norwegian law requires
disclosure of origin and prior informed consent in its national law.
At the last WIPO IGC meeting Norway tabled a complementary proposal on traditional
knowledge." It requires that the source and origin of traditional knowledge also be
disclosed in patent applications although it is not linked to genetic resources.i"
2~There are several contentious areas that have been raised. Examples include: Is there a need to disclose
more than source (asked by Switzerland? Why is the term "biological" resource used instead of "genetic"
resource (EU and the Philippines)? What is to be understood by the term "associated traditional
knowledge" (EU)? Will the requirement to publish require publication with the patent or separately from
the patent applicati.on (EU)? The sponsors of the amendment have answered these questions.
27 IP Watch, WIPO, 25 April 2006.
28 On this point, and some other areas, it differs from the EU's proposal at WIPO although it is similar.
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II. WORLD INTELLECTUAL PROPERTY ORGANISATION - WIPO
In 2004 Brazil introduced the development agenda at WIPO. This includes proposals for
the protection of traditional knowledge, traditional cultural expressions (folklore) and
genetic resources. These negotiations ended in a stalemate at the last meeting of the
intergovernmental committee held in June this year - 2006 - over whether to address
substantive legal text before completing work on objectives and principles.
At the heart of this debate is the desire of Brazil, South Africa (on behalf of Africa), India
and others to include issues including on TK as part of the whole negotiation so that it
might lead to a legally binding instrument for the protection of these areas. But Japan, the
United States and others are against their inclusion before the completion of talks about
principles and objectives which they say would represent a foundation for further
discussions.
The substantive provisions deal, among other matters, with protection against
misappropriation, the legal form of the protection and fair and equitab e benefit-sharing
and recognition of knowledge holders and prior informed consent.
The position of the industrialized countries and their bioindustry is that the enforcement
of ABS should be separate from the administration of patent rights; that contracts
between countries made on mutually agreed terms and not an internationally binding
instrument should resolve the problem; and that there should be developed a universal
system to harmonise existing TK databases and digital libraries_29
The committee will meet again on 4-12 December 2006, at the halfway point of its two-
year mandate.3o
III. THE CONVENTION ON BIOLOGICAL DIVERSITY
The Convention on Biological Diversity (CBO) provides an international recognition of
the ownership rights of countries over their genetic resources. This was important for the
South which holds most of the biological resources and diversity of the world. A key
feature of the CBO is Article 16(5) which establishes that Parties will cooperate to make
sure that any intellectual property rights do not run counter to the objectives of the CBO-
29 See for example, 'Comments of the American Bioindustry Alliance on WIPO Paper
WIPO/GRTKlIC/9/S, 'The Protection of TK: Revised Objectives and Principles', July 31 2006. The ABIA
was established by the American biotechnology companies to voice their positions at, among others,
international fora - WTO, CBD and WIPO. Its members include: Pfizer, Merck, Bristol Myers Squibb,
General Electric, Eli Lilley and other leading biotech and pharmaceutical industry players.
30 The debate focused largely on 2 documents: WIPO/GRTKF/IC/9/4; and WIPO/GRTKF/IC/9/S.
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the conservation and sustainable use -of biodiversity and its components and the fair and
equitable sharing of the benefits from the utilization of genetic resources.
Establishing an International Regime on Access and Benefit Sharing (ABS)
The th meeting of the Conference of the Parties in Kuala Lumpur in 2004 - COP7 - set
in motion negotiations for an International Regime (lR) on access and benefit sharing of
genetic resources. It established a working group and provided the terms of reference.
The scope of the potential IR includes TK, innovations and practices in accordance with
Article 8(j) of the CBD. Among the elements in the terms of reference are: measures to
ensure with the prior informed consent of indigenous and local communities holdoinf TK
associated with genetic resources; internationally recognized certificates of
origin/source/legal provenance of genetic resources and associated TK; disclosure of
origin/source/legal provenance of these in applications for IPRs, and the recognition and
protection of the rights of indigenous and local communities over their TK associated to
genetic resources 'subject to national legislation'.
The working group, after 2 meetings, has produced a heavily bracketed text in Granada in
2005 representing a range of often diametrically opposing views on many key facets.
COP8 held in Brazil in March 2006, agreed to continue negotiations on the IR on the
primary basis of the Granada text. The next round of negotiations is expected to be held
in mid-2007. A clear schedule of work has been set. It was also agreed that the
negotiations be concluded 'as soon as possible and in any event no later than COP 10
scheduled for 2010'.
The decision highlights, as a possible measure for the development of the international
regime, the disclosure of origin/source/legal provenance of genetic resources in IPR
applications in national jurisdictions - in accordance with Art 16(5) of the CBD.
A group of technical experts will be appointed and they will prepare a report on the form,
intent and functioning of an internationally recognized certificate of origin/source/legal
provenance. In particular the group is to look at its usefulness in fulfilling the objectives
of the CBD, in particular Articles 15 and 8(j). The issue of the desirability of this
certificate is left open. The group i-sexpected to meet early next year - 2007.
COP 8 also dealt with national measures that countries can take to support compliance
with the prior informed consent (pic) and mutually agreed terms (mat) provisions of
Article 15 of the CBD. It urges Parties and others to continue taking such measures as
will support compliance with pic and mat -where there is utilization of genetic resources
or associated traditional knowledge - in accordance with Article 15 of the CBD and
national legislation.
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Developing countries are firm that derivatives are not excluded from the scope of the
decision. They consider the expression in the decision - utilization of genetic resources
and associated traditional knowledge - to include the use of derivatives from genetic
resources. Utilization of genetic resources in the context of the CBD means the use of
any larger or smaller part, extract or chemical compound from plant, animal, microbial or
other origin containing genes. The CBD in Article 2 does not define genetic resources on
the basis of its reproductive functions but on the basis of its composition. Thus, the aims
pursued with such an utilization are not restricted to the reproductive capabilities of a
genetic resource, example: propagation or using isolated genes, but to all kinds of use.
Thus, utilization of genetic resources would include activities like the production of
cosmetics based on the use of plant material, drug development based on the use of
marine microorganisms, or, of course, using isolated genes in modem biotechnology.
In any event, it is for a country to define by its national legislation what use of genetic
resources is to be disclosed in the certificate. It is for a country then to require the
disclosure of pic and mat in relation to derivatives.
Cooperation with the Working Group (WG) on article 8(;)
The Article 8(j) WG have expressed a clear call for the ABS WG developing the
International Regime (IR) to work in tandem with them on all mattersrrelating to TK. It
has asked for the mandate to elaborate specific elements and measures relevant to the
protection of TK associated to genetic resources in the IR. It has also asked for the
creation of an advisory group - consisting of indigenous peoples and local communities -
to undertake a review of the negotiations of IR and to provide ex~ert advice to both the
Working Groups on matters relating to the protection of GR-TK. ) This request has not
been acceded to by COP8. It has decided nonetheless to allow for full and effective
participation of indigenous peoples and local communities in all matters relating to TK in
the fevelopment of the IR within the rules of procedure. Specifically, they request them
to provide their views so that these can be compiled and made available to the ABS WG
and invites chairpersons to 'facilitate the effective participation of their representatives'
and to 'consult them, as appropriate, on issues related to TK, innovations and practices
and associated genetic resources, ... in accordance with the rules of procedure'. 32
IV. UN CONFERENCE ON TRADE AND DEVELOPMENT - UNCT AD
The 2004 COP7 invited UNCT AD to analyse issues relating to the implementation of
disclosure of origin requirements in the IPR system. Its principal finding was that there'
was a need for 'an international system of mandatory disclosure of origin requirements to
prevent misappropriation of genetic resources and associated TK, to promote compliance
31 Presentation to COP8 by the International Indigenous Forum on Biodiversity, Brazil, March 2006.
32 Decision VIII/5, UNEP/CBD/COP/8/31, p. 67. The Rules of Procedure allow non-Parties to participate in
any meeting as observers upon invitation of the President 'unless at least one third of the Parties present at
the meeting object'. In any event observers have no right to vote: rules 6 and 7.
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with the CBD access and benefit sharing provisions, and to prevent misuse of the IPR
system. The report noted that because not all countries had laws imposing these
disclosure requirements, there was a need for a new international treaty provisions to
assure worldwide implementation of such disclosure requirements.r' It recommended that
these provisions be included in the WTO because of its broad membership and dispute
settlement procedures" It was of the view that although the disclosure requirements
were compatible with WIPO-administered treaties, those treaties ' ... were not adopted
with disclosure of origin requirements in mind'. In so far as they may be incompatible
then those WIPO treaties had to be amended." The Report also recommended the need
for addressing a number of issues in the PCT regime. These included revising rules and
adopting new procedures.i"
v. THE INTERNATIONAL TREATY ON PLANT GENETIC RESOURCES
FAO
The treaty, negotiated and concluded under the UN Food and Agricultural Organisation
(FAO), deals with plant genetic resources for food and agriculture (PGRF A). 37 It
establishes a specific mode of establishing access and benefit sharing in respect of
particular categories of genetic resources - those for food and agriculture. The treaty
establishes access and benefit sharing for a list of 35 crops and crop complexes and 29
forage speciea " This list can be expanded by consensus of the government parties to the
FAO. Non listed genetic resources can also be the subject of mutual access and benefit
sharing modeled on the treaty.
These crops have crossed boundaries since 100s of years ago. The whole world is
interdependent upon them." They have been developed by indigenous and local
communities of farmers - primarily in developing countries. Many germplasms of the
popular cops are in ex situ collections - situated in, or often owned by - developed
countries. There have been international exchanges and access to these materials for
research, breeding and production. Individual cultivars are also accessed. There are over
6 million crop accessions held worldwide in some 1400 gene banks. As an example
33 Joshua SamofTand Carlos Correa, Analysis a/Options/or Implementing Disclosure a/Origin
Requirements in Intellectual Property Applications. UNCT AD, 2006, p. iv.
34 A .t p. IX.
is A .t p. XI.
36 A ..t p. XII.
37 It came into effect on June 2004.
38 Not included are some crops of great value to sustainable agriculture and food security such as: soya
bean, groundnut, many fruits and vegetables and tropical forages. Others that are not so wide spread
include: African leafy vegetables which are potentially important as they provide nutritional well being of
the populace of many developing countries and regions.
39 Wheat came from Europe to the Americas over 500 years ago, finger millet was domesticated in Africa
4000 years ago and introduced to South Asia some 4000 years ago, maize was introduced to Europe from
America on Columbus' return and then taken to Africa and managed and further developed there for more
than 500 years, barley was introduced to Ethiopia more than 2000 years ago: IPGRI and IRR1, Developing
Access and Benefit-sharing Regimes: Plant Genetic Resources for Food and Agriculture, Feb 2005, pp. 1-
2.
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researchers on ground nut - originally from collections in Uganda and Kenya - would
most likely collect them from the ICRISA T centre in India. This centre obtained 67% of
its accessions from non Kenyan/Ugandan sources.40 So researchers often obtain
germplasms from outside the country of diversity of the crop. Figures from IPGRI and
IRRI's publications show that nearly all countries are net recipients of plant genetic
resources. Countries have also benefited by multiplying between 2 and 20 times as many
varieties as they have contributed to the accessions.41 Also on average each variety of
individual crops was a mixture of 7 land races from 4 or 5 different countries. In other
words countries were dependent on foreign progenitors for their breeding programmes;
for rice - up to 83%.
32
For this reason it is very difficult, if not impossible, to calculate the incremental
contribution for each ancestors to the development of the improved varieties,
advanced lines and Iandraces in existence. Even more complex is the difficulty in
assessing the qualitative contributions of each parent parents to their progeny.Y
Additionally, crop research is also done across institutions using a wide range of
resources. Accessing these could entail a large number of material transfer
agreements. IPGRIIIRRI's publication gives an example. IRRI's over 80,000
accessions are from 11 countries. 110 agreements would have to be negotiated to
gain access. For all countries to get access to all of the material would require 12, 210
agreements. This would result in high transaction costs and mucfi time.
This underlines the need for a multilateral system for access and benefit sharing.
Access under the treaty
Contracting Parties agree to give access to the crops listed in Annex 1 when these are
in the public domain and under the management and control of the Parties.
43
Access
should be for free or at a minimal cost. There can be no IPR or other rights claimed
that could limit the facilitated access to the genetic resource or their genetic parts or
components 'in the form received by the multilateral system'.
Benefit sharing
This is structured on a multilateral basis. The access is considered as the biggest
oenefit. Others include: exchange of information, access to and transfer of
technology, capacity building, and sharing of monetary benefits from
commercialisation. Those who commercialise products and incorporate that material
will pay a share of the benefits arising from the commercialization into financial
40 Preceding note, at p. 4, footnote 8.
4 IPreceding note, at p. 2.
42 See however the UNDP report cited earlier and the figures provided by the Rural Advancement
Foundation International (RAFI).
43 This includes Annex I materials held in the ex situ collections of the Future Harvest Centres. The treaty
states that the Centres' non-Annex] materials will be made under substantially the same conditions.
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mechanism set up under the treaty. The payment is mandatory where restrictions are
placed on the availability of the product to others for further research and breeding.
Otherwise it is voluntary. These funds will be used to support conservation and crop
improvement, especially in developing countries and those in transition. This is the
mechanism devised to share the monetary benefits with the fanners - providers of TK
- in developing countries.
The terms and conditions are standard. There will be no bilateral agreements. This
saves time and transaction costs.
Farmers' Rights
The Treaty recognizes the need to protect knowledge and innovations in fanning
under_ sui generis national Plant Variety Protection laws. These rights can be
incorporated in such a law as long as It otherwise provides 'effective' protection to
plant breeders.
CONCLUSION
There are large number of international fora now addressing issues in' relation to
genetic resources and TK. What should the synergies be between these organizations?
Who should take ownership of these processes? Or, at least, be the lead organization?
Where would the enforcement be most effective? These issues have yet to be
-addressed in a holistic manner. The horizontal cooperation is foreshadowed by the
FAO's work undertaken in harmony with the CBD. As well, paragraph 19 of the
DOHA WTO Ministerial implies the need to ensure the compatibility of the WTO
and the CBD.44 These several initiatives reflect the seriousness with which
developing countries are pursuing the creation of a binding international agreement
for the protection of TK against misappropriation. Although it is difficult to predict
the precise outcome, or the time frame for its realization, what appears certain is that
the journey towards that goal has commenced in earnest.
PART 7: NATIONAL EFFORTS
TRIPS provisions: Defensive basis for safeguarding
44 Paragraph 19 of the Declaration ',. instructs the Council for TRIPS, in pursuing its work programme
including under the review of Article 27.3(b), the review of the implementation of the TRIPS Agreement
under Article 71.1 and the work foreseen pursuant to paragraph 12 of this Declaration, to examine, inter
alia, the relationship between the TRIPS Agreement and the Convention on Biological Diversity, the
protection of traditional knowledge and folklore, and other relevant developments raised by Members
pursuant to Article 71.1 '.
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Many developing countries have introduced, or are in the process of introducing, national
laws and policies for the protection of TK associated with genetic resources. Such efforts
must necessarily keep in mind the overarching provisions of the obligations under
TRIPS.
TRIPS is silent on genetic resources, TK, folklore and biodiversity. There are however
provisions that can be interpreted as providing a defensive basis for preventing the
misappropriation of genetic resources and TK.
One is Article 7 which provides:
The protection and enforcement of IPRs should contribute to the promotion of
technological innovation and to the transfer and dissemination of technology, to the
mutual advantage of producers and users of technological knowledge and in a manner
conducive to social and economic welfare, and to the balance of rights and obligations.
The other is Article 27.2 which allows for the exclusion of patents on the ground of
public order or morality, including prejudice to the environment. any unfair abuse or
exploitation of genetic resources may thus be prevented.
Article 67 can also be invoked to require assistance from developed countries to prevent
abuse of IPRs.
These Articles do not confer rights on genetic resources associated with TK, but they
could be read as allowing for remedial or preventive measures against abuse."
The implications of the absence of any specific provisions in TRIPS on TK means that
members are free to amend their IPR laws to protect TK; or introduce sui generis laws to
protect TK. The laws they enact will be to implement the CBD, in particular Article 8(j) -
so long as it does not conflict with TRIPS.
Sufficient flexibilities in TRIPS
There are also sufficient flexibilities in TRIPS that developing countries can rely upon in
formulating laws and policies in relation to TK that are compatible with their stage of
development and needs and cultural values. The issue of the protection of TK must be
preceded by careful analysis - not only of the rights holders, but the possible implications
of protection for public health, food security and other public interests.l"
The flexibilities under TRIPS that provide room for drafting laws and policies protective
of TK and genetic resources stems from the definition of invention, the requirements of
45 Weerawit Weeraworawit, 'International Legal Protection of Genetic Resources, TK and Folklore:
challenges for the IP system', in Trading in Knowledge. Bellman, Dutfiled and Melendez-Ortiz (eds),
Earthscan, 2003, at p. 161.
46 Carlos Correa, 'Formulating Effective Pro-development National Intellectual Property Policies', in
Trading in Knowledge. Bellman, Dutfiled and Melendez-Ortiz (eds), Earthscan, 2003, at p. 216.
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protection and the possible exceptions to patentability." The options available to
developing countries in this regard can be summarized as follows:
1. As the term 'invention' is not defined in TRIPS and since there is no accepted
universal concept of the term, developing countries can adopt a definition that excludes
materials pre-existing in nature. The decision to do so can be based on principle or on
technical and economic considerations
This is the position adopted by
Decision 344 of the Andean Group, article 6.b - substances that exist in nature
and their replication are not inventions;
Argentine Patent law, article 6.g - excludes from the concept of invention 'any
kind of living material or substance already existing in nature;
Brazilian Patent law, article lO.lX - no invention can be claimed with respect to
'the whole or part of natural living being and any natural biological processes'.
2. TRIPS obliges members to protect products and processes but not uses of a known
product for pharmaceutical purposes. Such an invention relating to use of a product may
be considered un-patentable because it consists of the discovery of an existing property
rather than a new development, or because it falls under the exclusion from patentability
of therapeutical methods - allowed by TRIPS and most national laws. It is suggested that
the non-patentability of uses of an existing substance may avoid some cases of biopiracy
- in which a substance found in nature is patented on the basis of the identification of a
certain therapeutic use."
3. The novelty requirement can be deemed lost when an invention is divulged anywhere _
inside or outside the country - including by non-written means such as public use and
sale. The US only recognizes does not recognize non-written means. Only publications
made abroad destroy the novelty. This has permitted the US applicants to claim as novel
inventions based on materials that are developed and used by indigenous and local
communities and that constitutes their TK. Examples are the patents filed in respect of
the neem, tumeric, basmati rice lines.
4. Providing for the exclusions from patentability of inventions that are considered to be
against order public and morality. These terms are fairly fluid and it is for countries to to
define the basis upon which exclusions will be allowed. Implementing the exclusion
relating to order public would rest upon one's notion of what is needed to protect public
values. The concept extends to the protection of human. Animal or plant life or health
and may be applied to inventions that may lead to 'serious prejudice to the environment':
article 27.2. The concept of morality is also based on the conception and values of a
47 Carlos Correa, IPRS, the WTO and Developing Countries: The TRIPS Agreement and Policy Options,
TWN, 2000, at p. 51 on - on which this part is largely based.
48 Previous footnote, at p. 56.
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society. So long as it is reasonably based on these values, it would appear to be consistent
with TRIPS.
5. Article 27.3(b) requires a form of protection for plant varieties. It could be new and sui
generic. National laws can require such conditions as the obligation to declare the origin
of materials used and to give evidence of the country of origin! source and the indigenous
and local community whose TK is involved. It could also provide for the need for fair
and equitable benefit sharing with these countries and communities.Y
It was earlier noted that COP 8 also dealt with national measures that countries can take
to support compliance with the prior informed consent (pic) and mutually agreed terms
(mat) provisions of Article 15 of the CBD. The decision urges parties and others to
continue taking such measures as will support compliance with pic and mat -where there
is utilization of genetic resources or associated traditional knowledge - in accordance
with Article 15 of the CBD and national legislation.
6. If the patentability of plants and animals is allowed, national laws may also incorporate
specific provisions to limit the extent of the exclusive rights, especially relating to the
multiplication of the protected materials. So patent owners, for example, should not be
able to prevent the replanting of patented seeds or the exploitation of the progeny of
d . I 50patente anlma s. : .
The EC Directive on the Legal Protection of Biotechnological Inventions allows the
replanting of patented seeds without remuneration in the case of small .farmers. 51
For patents relating to breeding stock or other reproductive material, the farmer is entitled
to use the protected livestock for an agricultural purpose but cannot sell the material
'within the framework or for the purpose of a commercial reproduction activity'. 52
Other measures taken at national level
Law onfarmers' rights
Some developing countries have modelled IPR laws to respond to their social and
economic conditions. The Indian Protection of Plant Varieties and Framers' Rights Act
2001 is an example. It was enacted to fulfill the sui generis option in article 27.3(b) of
JRIPS. There are comprehensive provisions relating to the rights of farmers - to save
harvested seed of protected varieties and also to sell it as long as it is not under the
protected brand name. There is a fund that must be paid into whenever breeders use
farmers' varieties. The law also requires full disclosure of the source and origin of
49 South Africa has amended its Patent legislation to effect the disclosure requirement thereby combining
the CBD requirements with traditional knowledge protection - along the lines of the proposals on article
29bis of TRIPS at the WTO.
50 Previous footnote, at p. 89.
51 Directive No. 98/44/EC, 6 July 1998, article 11.1. There is a similar provision in the Malaysian Plant
Variety Protection Act.
52 Directive No 98/44/EC, article 11.2.
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varieties and complete passport data from breeders - with heavy penalties for non-
disclosure.
Documenting TK
This is being documented and published so that the innovation is in the public domain
and cannot be misappropriated.
TK Digital Library
For much the same reason, the Government of India is developing a digital database of
public domain TK related to medicinal plants. It is intended to make this available to
patent offices in the world so that the examiners are aware of the prior art relating to a
particular medicinal plant India spent several million dollars canceling the patents in
respect of tumeric and the neem and the basmati rice. Patents are granted almost routinely
by examiners too over burdened with applications to carry out a proper prior art
examination. There are about 3 million patents applications pending in the three main
patent offices in the world - the US, the EU and Japan. The patent system is in crisis and
the examiners can do little more than grant the patent. There seems to be a reversal of the
burden - a patent is granted unless there is shown evidence to the contrary that it does not
satisfy the criteria for patentability. There are reported to be some 2500 patents granted in
error. And 500 more are added to every year!
Brazil has also recently forwarded to WIPO, the WTO and trademark offices throughout
the world a 'Non-Exhaustive List of Customary Names used in Brazil associated with
Biodiversity' It aims to prevent the registration of trademarks, without sufficient
distinctive character, by providing trademark offices and examiners an important basis
for consultation. It has had to do this as it exporters faced losses and it had to undertake
costly proceedings to cancel filings or invalidate registration of generic names of its
biodiversity and cultural heritage. This includes TK. This has hampered its
commercialization of Brazilian commodities and products abroad. 53
Other developing countries have also adopted data bases and registries for TK and
genetic resources both individually and through regional initiatives. These include: the
Traditional Chinese medicine Patent Database of China; the system of national and local
registers established under Peruvian Law 278111; and the Biozula Data Base in
~Venezuela, which covers native medicines, ancestral technology and traditional
agricultural knowledge.
NGO established Databases on TK
The American Association for the Advancement of Science Project on Traditional
Ecological Knowledge together with a host of other NOOs has set up the Traditional
Ecological Knowledge Prior Art Database which is an index and search engine of
existing internet-based, public domain documentation concerning indigenous knowledge
S3 Press Release, Permanent Mission of Brazil in Geneva, 24 July 2006.
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and plant species use. Its web site" states that this database brings together in a single
location, various types of public domain data necessary to establish prior art. Data
includes taxonomic and other species data, ethnobotanical uses, scientific and medical
articles and abstracts, as well as patent applications themselves. There have been
concerns expressed that this public system of TK databases or digital libraries could
provide a licence to steal - as there is a neat cataloging of genetic resources and
associated TK that is readily accessible to commercial researchers and scientists. This is
strenuously denied by industry. 55
Developing countries have been grappling with this problem of dealing with the
misappropriation of its genetic resources and associated TK for a long time. TRIPS and
the review process - more than anything else - have prompted developing countries to
seek a rectification to a long festering inequity. Various options have been advanced - at
both the national and international levels. These represent a plethora of possible, often
creative, solutions to what is now acknowledged as a complex problem.
CONCLUSION
~4 http://ip.aaas.org!tekindex.nsf
~~'Comments of the American Bioindustry Alliance on WIPO Paper WIPOIGRTKlIC/9/5, 'The Protection
ofTK: Revised Objectives and Principles', July 31 2006. See further: footnote 29.
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ECON CONTRIBUTION
• AGRICULTURAL CROPS
- 15 MAJOR CROPS: MORE THAN US $50b In
ANNUAL SALES IN US (UNDP study)
- WHEAT & MAIZE: IM&WC: US $2 b in CROP
PRODUCTION in indus. countries
- RICE: IRRI: US $655 m p.a.
- RICE: FROM TRAD CROP VARIETIES: US $400 M
p.a. GLOBAL VALUE
- BEANS: US $111 M from ICTA
- ALSO: potato, chickpea, barley, livestock breeds, etc
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Impairment- conceptual - CONTD
• 2. USURPATION OF TK THROUGH IPRS
- THIS BIAS UNIVERSALISED THRU TRIPS
- DEFINITIONAL CONSTRUCTS FOR
PATENTS -NO PROTECN AND RECOG OF
INDIG INNOVN
• ONLY RECOG INDIVIDUAL NOT COMM
INVENTION
• ONE-OFF INV versus INTER-GENRATIONAL;
• FOR INDUSTRIAL APPLlCN versus SOCIAL
GOOD
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RESULT: BIOPIRACY
• MANY EXAMPLES- FROM TK BUT KN
ITSELF DEPRECATED AS 'PRIMITIVE
- NEEM - 34 PATENTS BY US/JAP COYS:
KN 5000YRS
- TUMERIC, DEVIL'S CLAW.
SANGRADERAGO : SOME CHALLENGED
SUCCESFULL Y
- ROOT OF SERPENT-WOOD SPECIES
HYPERTENSIVE DRUG
. • 1967 -90% ANTI·H DRUGS BASED ON IT .: .'
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RESTORING BAL - CONTD
• 2. ACK CO-EXISTENCE OF THE 2 SYS?
- RECOGN PLURAL & DIFFERENT
- NO OBJECTIVE BASIS FOR SAYING ONE
SUP TO OTHER
- MERE SOCIETAL CHOICE NOT
DEFENSIBLE BY OBJECT CRITERIA
- Eg CURARE PLANT: 40 types of plants. This
from w amazon. Combined - boiled 72 hrs -
must avoid vapors - final product+ paste -
. "must be injected under skin '.!
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Contd - options - mainly national
• CONTRACTS - contd
- Vernonia (oil seed crop): Ethiopia Inst of Biod
Conservn and UK Vemlque Biotech Co -royalty, non-
monetary benefits etc: July 2006
• CUSTOMARY LAW & PRINCIPLES
- Free xchange & access to COllective Bio-cultural Res
( kn, innovns and practices of i-lc held COllectively,
linked to trad res & territories, incl genes, varieties,
species, ecosys; cultural & spiritual values; and cust
laws shaped w/i soci-ecol contxt of comm);
- Recogn of coli custodianship;
- Promo reciprocal and equal xchange;
-. Resp use & conservn -cooe of ethics & 'equilibrium' •
, " -;.. ,- •... --.......__..,•.-....._..... "c. • ~""X·...., .......... ' . ,_. . .. .'
'. . •. ~.. . • ..",·",·~9"··"'~.
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regional
• Norm setting
• ASEAN FRAMEWORK AG ON ABS. 1996
• CENTRAL AM AG DRAFT. 2001
• ANDEAN COMMUNITY DECISION 391 -
COMMON REGIMES ON ACCESS TO
GENETIC RESOURCES. 1996
• AFRICN MODEL LEG FOR THE PROTECN OF
THE RTS OF LOC COMM. F AND BREEDERS
AND FOR THE REG OF ACCESS TO BIOL
RES. 2000
t;,-.._~.."X~;,,~:::,~!:,~:.,~"',',,_~~~~~~~~,~
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CONTD - WTOITRIPS
• EMERGENCE OF PROPOS: b'ground
- 1995: INWTO/CTE - discussions began
- 1999: INTROD BY DG C WHEN TRIPS REVIEW of a
27.3(b)
- 1999: SEATTLE MIN: propos to amend trips to inc
TK
- 2001: DOHA MIN: instructed TRIPS C - xmine
CBDITRIPS rls & prot TK and f'lore
• 'outstanding implemn issue'
• Now outstanCiing issue al TNC level
- 2005 HK MIN: WTO DG to intensify consultative
process and rept to TNC & GC - which will take
action end of July 2006 .
~~.~~C-:':';:"" .:..-~-<-:....., "~"'::\<~~"i:~:~
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CONTO - WTO/TRIPS
• ELABORATION OF PROPOSALS
- FAIR & ENHANCE PAT SYST'S
CREDIBILITY
- 'FAIR & EO' CRITERIA:
• MAT -A. 15.7 CBD: COVERING ELEMENTS RE:
CONDNS. OBLIGNS, PROC. TYPES. TIMIMG.
DISTRIBN. MRCHANISM OF BENEF SHARED
• REPORTING OBLIGN ON ISSUES re:PAT OR
COMMERCLSN - ESP WHERE FUTURE BS
INTENDED
~o ~-. <'~'~'-'~<~<--'-'~'::"'"'':1tj'ili1-~2,
CONTO
• CONTO
- SANCTIONS & PENALTIES
• PLUS PENALTIES - INC CRIMNL
• TIME LIMIT TO SUBMIT - OTHERWISE DEEMED
W/DRAWN. APPLlCN NOT PROCESSED
• WHERE DISC'D AFTER GRANT OF PAT
- REVOCN OF PAT -IF INTENT FRAUOLNT
- AOD OR ALTVE - CRISDMINVE SANCTIONS -INCL
ADEQ COMPENSN
- FULUPARTIAL TRANSFER OF RTS TO INVENTN
- CRiCIVIL SANCTIONS OUTSIDE PAT SYS -INC
~...,~.- ..,.~~rr.1~~~~·.:-·~~7·'.~·;t~51Jj~J
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contd
• Contd
• 3. WHAT 3 TRIGGERS MEAN IN PRACTICE?
- COVERS SITUATIONS IN WHICH TK
CONTRIBUTED TO INVN
• 'CONCERNS': WtiERE PREDOM OR SUBSTAN PART OF
INVEN INCORPORATES THE GR. SAME AS IN EU OIR
96/44
• 'DEVELOPED WITH': MAY NOT NECESSARILY
INCORPORATE ANY OF GR BUT TK CRITICAL TO OEV
OF INVEN
• 'OERIVED FROM': COVERS DERIVATIVES. IN A 8.1 OF
EU OIR - REFERRING TO PROPAGNIMULTIPLICN FROM
ORIGMATERIAL. .. . .. . :; .. ' ,,' .
L/·,--.....-_., .~.~~~: .7".~) ~+','<~rj~~.:·"or..:~
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contd
• They and bioindustry: enforcement of ABS should be
separate from the administration of patent rights; that
contracts between countries made on mutually agreed
terms and not an intemationally binding instrument
resolve problem; and that there should be developed a
universal system to harmonise existing TK databases
and digital libraries
• The committee will meet again on 4-12 December 2006.
at the halfway point of its two-year mandate.
• The debate largely on 2 documents:
WIPO/GRTKFIIC/9/4; and WIPO/GRTKFIIC/9/5 .
. • SEE EARLIER: POSN OF EU AND NORWAY@ WIPO.(
• -, "'~-""" ..- ...... -...... ....-'-- ,;..> '.: • .....-.:.", :,.t>' _.- .........- __ .' ~.~"",.....~'~'. ,'~' ..".,."',' ." ~·/..~~~t7.:~;~'iI
2.WIPO
• In 2004 Brazil introduced the development agenda :
Proposals: among other matters. protection against
misappropriation. the legal form of the protection and fair
and equitable benefit-sharing and recognition of
knowledge holders and PIC.
• Negs stalemate at meeting of IGC in June 2006 . ISSUE:
W? to address substantive legal text before completing
work on objectives and principles.
• DG Cs - Brazil, South Africa (on behalf of Africa), India
etc including TK as part whole negotiation -tead to
legally binding instrument.
• Japan, the United States, etc against their inclusion
before the completion of talks about principles and
objectives as 'foundation for further discussions'.
~. ·- ..... L'· --....._~".-..:,~ ..... -:'-.:-:.::, .. :'~'~-:C::,~:
3.CBD
• IR ON ASS; BY COP7 IN KL - 2004
• ESTDWG.
• TOR incl TK as in A. 8(j). PIC. certs of origin etc.
disclosure in IPR applications. protectn of l-lc
over their TK subj to nat leg
• 2 mtgs
• COP 8 '06: continue neg on Granada Text.
• Schedule of work: finish by 2010
. • Experts to meet on Cert of Origin in. IPRs , ,
l.,/-" _- :"""'~~'~<:~:'~;''''''." :iZS"~"
CONTD
• Ps AG GIVE ACCESS TO CROPS LISTED - when in
public domain and under m'ment and control of Ps. No
IPR rts Ihat will limit fac access 10 gr or component parts
'in the form rec'd by Ihe mls.
• B-sh: multilat basis - those who comm products and
incorporate mat pay a share to tinan mechanism
• If restrictions on availability of prod 10 others for further
research and breeding - then mandatory
• If nOI- voluntary
• Funds used 10 support cons & crop imp'ment • -esp 09
Cs .
~>:~~~.~~S~~_:I~~st~~~~ MTA~",""" . '. 'c'l
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contd
• CHALLENGES 09 Cs FACE IN THIS
AREA:
- MIN IPR STDS BACKED BY TRADE
RETALIATION
- LOSS AND BALANCE OF IPR POLICY &
RULES- incl dangers by FTAs
- UNDEMOCRATIC AND IDEOLOGICAL STD-
SETIING PROCESSES
-INCONSIS AND LACK OF CO-ORDN
WITHIN AND AMONG Dg Cs '.
L.>.- ,-," ",",. '!-':~ :;'.. ;i",,-:~ -"':' "',.'>'_s~~d~':~~~
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